TreeWAS – Variant ID: rs10507047

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I25.1 Atherosclerotic heart disease	0.000	0.832	0.168
I20.0 Unstable angina	0.000	0.860	0.140
I20 Angina pectoris	0.000	0.861	0.139
I20.9 Angina pectoris, unspecified	0.000	0.863	0.137
I25 Chronic ischaemic heart disease	0.000	0.864	0.136
I20-I25 Ischaemic heart diseases	0.000	0.874	0.126
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.876	0.124
I25.5 Ischaemic cardiomyopathy	0.000	0.887	0.113
I25.3 Aneurysm of heart	0.000	0.900	0.100
I25.6 Silent myocardial ischaemia	0.000	0.902	0.097
I23 Certain current complications following acute myocardial infarction	0.000	0.909	0.091
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.912	0.088
I20.1 Angina pectoris with documented spasm	0.000	0.913	0.087
I20.8 Other forms of angina pectoris	0.000	0.920	0.080
I22 Subsequent myocardial infarction	0.000	0.921	0.079
I25.4 Coronary artery aneurysm	0.000	0.924	0.076
I21 Acute myocardial infarction	0.000	0.929	0.071
I23.8 Other current complications following acute myocardial infarction	0.000	0.935	0.065
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.000	0.935	0.065
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.000	0.935	0.065
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.000	0.935	0.065
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.000	0.935	0.065
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.000	0.935	0.065
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.000	0.935	0.065
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.000	0.935	0.065
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.936	0.064
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.937	0.063
I21.3 Acute transmural myocardial infarction of unspecified site	0.000	0.943	0.057
I22.8 Subsequent myocardial infarction of other sites	0.000	0.947	0.053
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.948	0.052
I21.X Presumed acute myicardial infaction (unconfirmed)	0.000	0.949	0.051
I21.9 Acute myocardial infarction, unspecified	0.000	0.950	0.050
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.951	0.049
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.951	0.049
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.951	0.049
K76.6 Portal hypertension	0.046	0.954	0.000
I24 Other acute ischaemic heart diseases	0.000	0.954	0.046
K76 Other diseases of liver	0.045	0.955	0.000
K70 Alcoholic liver disease	0.044	0.956	0.000
K70-K77 Diseases of liver	0.043	0.957	0.000
K70.3 Alcoholic cirrhosis of liver	0.042	0.958	0.000
K76.8 Other specified diseases of liver	0.040	0.960	0.000
K76.7 Hepatorenal syndrome	0.038	0.962	0.000
K74 Fibrosis and cirrhosis of liver	0.037	0.963	0.000
K70.1 Alcoholic hepatitis	0.036	0.964	0.000
K70.4 Alcoholic hepatic failure	0.035	0.965	0.000
K70.9 Alcoholic liver disease, unspecified	0.035	0.965	0.000
K74.6 Other and unspecified cirrhosis of liver	0.035	0.965	0.000
K70.0 Alcoholic fatty liver	0.035	0.965	0.000
K71 Toxic liver disease	0.034	0.966	0.000
K73 Chronic hepatitis, not elsewhere classified	0.034	0.966	0.000
I24.1 Dressler's syndrome	0.000	0.966	0.033
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.967	0.032
K76.5 Hepatic veno-occlusive disease	0.032	0.968	0.000
K76.4 Peliosis hepatis	0.032	0.968	0.000
K76.3 Infarction of liver	0.032	0.968	0.000
K76.2 Central haemorrhagic necrosis of liver	0.032	0.968	0.000
K76.1 Chronic passive congestion of liver	0.032	0.968	0.000
K75 Other inflammatory liver diseases	0.032	0.968	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.032	0.968	0.000
K76.9 Liver disease, unspecified	0.031	0.969	0.000
K77 Liver disorders in diseases classified elsewhere	0.031	0.969	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.027	0.973	0.000
K74.4 Secondary biliary cirrhosis	0.027	0.973	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.027	0.973	0.000
K74.1 Hepatic sclerosis	0.027	0.973	0.000
K75.0 Abscess of liver	0.027	0.973	0.000
K74.0 Hepatic fibrosis	0.026	0.974	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.026	0.974	0.000
K74.5 Biliary cirrhosis, unspecified	0.026	0.974	0.000
K73.9 Chronic hepatitis, unspecified	0.025	0.975	0.000
K71.9 Toxic liver disease, unspecified	0.024	0.975	0.000
K71.8 Toxic liver disease with other disorders of liver	0.024	0.975	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.024	0.975	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.024	0.975	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.024	0.975	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.024	0.975	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.024	0.975	0.000
K71.2 Toxic liver disease with acute hepatitis	0.024	0.975	0.000
K71.0 Toxic liver disease with cholestasis	0.024	0.975	0.000
K75.9 Inflammatory liver disease, unspecified	0.024	0.975	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.024	0.976	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.024	0.976	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.024	0.976	0.000
I25.2 Old myocardial infarction	0.000	0.976	0.024
N30 Cystitis	0.024	0.976	0.000
N30.8 Other cystitis	0.024	0.976	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.023	0.977	0.000
K75.2 Nonspecific reactive hepatitis	0.023	0.977	0.000
K75.1 Phlebitis of portal vein	0.023	0.977	0.000
K74.3 Primary biliary cirrhosis	0.023	0.977	0.000
K72 Hepatic failure, not elsewhere classified	0.023	0.977	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.022	0.977	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.022	0.977	0.000
N30.2 Other chronic cystitis	0.022	0.978	0.000
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.979	0.021
I35.1 Aortic (valve) insufficiency	0.000	0.979	0.021
N30.1 Interstitial cystitis (chronic)	0.021	0.979	0.000
K75.8 Other specified inflammatory liver diseases	0.021	0.979	0.000
N30.9 Cystitis, unspecified	0.021	0.979	0.000
N30.3 Trigonitis	0.021	0.979	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.980	0.020
K75.4 Autoimmune hepatitis	0.020	0.980	0.000
I24.8 Other forms of acute ischaemic heart disease	0.000	0.980	0.020
N30.0 Acute cystitis	0.019	0.981	0.000
I35 Nonrheumatic aortic valve disorders	0.000	0.982	0.018
I35.2 Aortic (valve) stenosis with insufficiency	0.000	0.982	0.018
K72.1 Chronic hepatic failure	0.016	0.983	0.000
I35.8 Other aortic valve disorders	0.000	0.984	0.016
N30.4 Irradiation cystitis	0.015	0.985	0.000
K72.0 Acute and subacute hepatic failure	0.014	0.986	0.000
I35.9 Aortic valve disorder, unspecified	0.000	0.987	0.013
K72.9 Hepatic failure, unspecified	0.012	0.987	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.012	0.988	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.012	0.988	0.000
I35.0 Aortic (valve) stenosis	0.000	0.988	0.012
C09 Malignant neoplasm of tonsil	0.012	0.988	0.000
C09.9 Tonsil, unspecified	0.012	0.988	0.000
C07 Malignant neoplasm of parotid gland	0.011	0.988	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.000	0.989	0.011
I21.4 Acute subendocardial myocardial infarction	0.000	0.989	0.011
C02.9 Tongue, unspecified	0.011	0.989	0.000
C02.2 Ventral surface of tongue	0.011	0.989	0.000
C03 Malignant neoplasm of gum	0.010	0.990	0.000
C11 Malignant neoplasm of nasopharynx	0.010	0.990	0.000
C02.4 Lingual tonsil	0.010	0.990	0.000
C01 Malignant neoplasm of base of tongue	0.010	0.990	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.010	0.990	0.000
C12 Malignant neoplasm of pyriform sinus	0.010	0.990	0.000
C04 Malignant neoplasm of floor of mouth	0.009	0.991	0.000
C13 Malignant neoplasm of hypopharynx	0.009	0.991	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.009	0.991	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.009	0.991	0.000
C05 Malignant neoplasm of palate	0.009	0.991	0.000
C00 Malignant neoplasm of lip	0.009	0.991	0.000
C02.8 Overlapping lesion of tongue	0.009	0.991	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.009	0.991	0.000
C02.0 Dorsal surface of tongue	0.009	0.991	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.009	0.991	0.000
C03.1 Lower gum	0.009	0.991	0.000
C09.8 Overlapping lesion of tonsil	0.009	0.991	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.009	0.991	0.000
C09.0 Tonsillar fossa	0.009	0.991	0.000
C11.9 Nasopharynx, unspecified	0.009	0.991	0.000
D41.4 Bladder	0.008	0.992	0.000
C10 Malignant neoplasm of oropharynx	0.008	0.992	0.000
C02.1 Border of tongue	0.008	0.992	0.000
C14.0 Pharynx, unspecified	0.008	0.992	0.000
C03.9 Gum, unspecified	0.008	0.992	0.000
C03.0 Upper gum	0.008	0.992	0.000
C11.8 Overlapping lesion of nasopharynx	0.007	0.992	0.000
C11.3 Anterior wall of nasopharynx	0.007	0.992	0.000
C11.2 Lateral wall of nasopharynx	0.007	0.992	0.000
C11.1 Posterior wall of nasopharynx	0.007	0.992	0.000
C11.0 Superior wall of nasopharynx	0.007	0.992	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.007	0.993	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.007	0.993	0.000
C14.2 Waldeyer's ring	0.007	0.993	0.000
C04.9 Floor of mouth, unspecified	0.007	0.993	0.000
C04.8 Overlapping lesion of floor of mouth	0.007	0.993	0.000
C04.1 Lateral floor of mouth	0.007	0.993	0.000
C04.0 Anterior floor of mouth	0.007	0.993	0.000
D41.0 Kidney	0.007	0.993	0.000
T42.4 Benzodiazepines	0.000	0.993	0.007
C00.9 Lip, unspecified	0.007	0.993	0.000
C00.8 Overlapping lesion of lip	0.007	0.993	0.000
C00.6 Commissure of lip	0.007	0.993	0.000
C00.5 Lip, unspecified, inner aspect	0.007	0.993	0.000
C00.4 Lower lip, inner aspect	0.007	0.993	0.000
C00.3 Upper lip, inner aspect	0.007	0.993	0.000
C00.2 External lip, unspecified	0.007	0.993	0.000
C00.1 External lower lip	0.007	0.993	0.000
C00.0 External upper lip	0.007	0.993	0.000
C05.9 Palate, unspecified	0.007	0.993	0.000
C05.8 Overlapping lesion of palate	0.007	0.993	0.000
C05.2 Uvula	0.007	0.993	0.000
C05.1 Soft palate	0.007	0.993	0.000
C05.0 Hard palate	0.007	0.993	0.000
C06.9 Mouth, unspecified	0.007	0.993	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.007	0.993	0.000
C06.2 Retromolar area	0.007	0.993	0.000
C06.1 Vestibule of mouth	0.007	0.993	0.000
C06.0 Cheek mucosa	0.007	0.993	0.000
C08.9 Major salivary gland, unspecified	0.007	0.993	0.000
C08.8 Overlapping lesion of major salivary glands	0.007	0.993	0.000
C08.1 Sublingual gland	0.007	0.993	0.000
C08.0 Submandibular gland	0.007	0.993	0.000
C13.9 Hypopharynx, unspecified	0.007	0.993	0.000
C13.8 Overlapping lesion of hypopharynx	0.007	0.993	0.000
C13.2 Posterior wall of hypopharynx	0.007	0.993	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.007	0.993	0.000
C13.0 Postcricoid region	0.007	0.993	0.000
H43.3 Other vitreous opacities	0.000	0.993	0.007
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.993	0.007
C10.8 Overlapping lesion of oropharynx	0.006	0.994	0.000
C10.4 Branchial cleft	0.006	0.994	0.000
C10.3 Posterior wall of oropharynx	0.006	0.994	0.000
C10.2 Lateral wall of oropharynx	0.006	0.994	0.000
C10.1 Anterior surface of epiglottis	0.006	0.994	0.000
C10.0 Vallecula	0.006	0.994	0.000
I27.2 Other secondary pulmonary hypertension	0.000	0.994	0.006
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.994	0.006
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.006	0.994	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.994	0.006
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.000	0.994	0.006
Y83.2 Surgical operation with anastomosis, bypass or graft	0.000	0.994	0.006
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.006	0.994	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.005	0.994	0.000
D41.9 Urinary organ, unspecified	0.005	0.994	0.000
D41.7 Other urinary organs	0.005	0.994	0.000
D41.3 Urethra	0.005	0.994	0.000
D41.2 Ureter	0.005	0.994	0.000
D41.1 Renal pelvis	0.005	0.994	0.000
H43 Disorders of vitreous body	0.000	0.994	0.005
T20-T25 Burns and corrosions of external body surface, specified by site	0.005	0.995	0.000
T21 Burn and corrosion of trunk	0.005	0.995	0.000
Z13.9 Special screening examination, unspecified	0.005	0.995	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.995	0.005
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.995	0.005
D38.1 Trachea, bronchus and lung	0.005	0.995	0.000
C10.9 Oropharynx, unspecified	0.005	0.995	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.995	0.005
Z40 Prophylactic surgery	0.000	0.995	0.005
D37-D48 Neoplasms of uncertain or unknown behaviour	0.005	0.995	0.000
H43.8 Other disorders of vitreous body	0.000	0.995	0.005
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.995	0.005
H43.1 Vitreous haemorrhage	0.000	0.995	0.005
T23 Burn and corrosion of wrist and hand	0.005	0.995	0.000
T21.3 Burn of third degree of trunk	0.005	0.995	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.995	0.005
I27 Other pulmonary heart diseases	0.000	0.995	0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.995	0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.995	0.005
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.995	0.005
T42.3 Barbiturates	0.000	0.995	0.005
T42.2 Succinimides and oxazolidinediones	0.000	0.995	0.005
T42.1 Iminostilbenes	0.000	0.995	0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.995	0.005
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.995	0.005
R20.2 Paraesthesia of skin	0.005	0.995	0.000
T21.0 Burn of unspecified degree of trunk	0.005	0.995	0.000
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.995	0.005
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.995	0.005
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.000	0.995	0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.995	0.005
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.005	0.995	0.000
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.004	0.995	0.000
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.004	0.995	0.000
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.004	0.995	0.000
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.004	0.995	0.000
T24.1 Burn of first degree of hip and lower limb, except ankle and foot	0.004	0.995	0.000
T23.2 Burn of second degree of wrist and hand	0.004	0.995	0.000
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.000	0.995	0.004
H43.9 Disorder of vitreous body, unspecified	0.000	0.996	0.004
T23.0 Burn of unspecified degree of wrist and hand	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.004
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
M17.0 Primary gonarthrosis, bilateral	0.000	0.996	0.004
T42.0 Hydantoin derivatives	0.000	0.996	0.004
T20 Burn and corrosion of head and neck	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.000	0.996	0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.996	0.004
T46.1 Calcium-channel blockers	0.000	0.996	0.004
T40.4 Other synthetic narcotics	0.000	0.996	0.004
H43.0 Vitreous prolapse	0.000	0.996	0.004
I27.0 Primary pulmonary hypertension	0.000	0.996	0.004
M51.0 Lumbar and other intervertebral disk disorders with myelopathy	0.004	0.996	0.000
T21.2 Burn of second degree of trunk	0.004	0.996	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
D38.0 Larynx	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.000	0.996	0.004
T25 Burn and corrosion of ankle and foot	0.004	0.996	0.000
T21.7 Corrosion of third degree of trunk	0.004	0.996	0.000
T21.6 Corrosion of second degree of trunk	0.004	0.996	0.000
T21.5 Corrosion of first degree of trunk	0.004	0.996	0.000
T21.4 Corrosion of unspecified degree of trunk	0.004	0.996	0.000
T21.1 Burn of first degree of trunk	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.996	0.004
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.996	0.004
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
T46.7 Peripheral vasodilators	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
I30-I52 Other forms of heart disease	0.000	0.996	0.004
Z40.8 Other prophylactic surgery	0.000	0.996	0.004
D45 Polycythaemia vera	0.004	0.996	0.000
D46 Myelodysplastic syndromes	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
D38.6 Respiratory organ, unspecified	0.004	0.996	0.000
D38.5 Other respiratory organs	0.004	0.996	0.000
D38.4 Thymus	0.004	0.996	0.000
D38.3 Mediastinum	0.004	0.996	0.000
D38.2 Pleura	0.004	0.996	0.000
T82.2 Mechanical complication of coronary artery bypass and valve grafts	0.000	0.996	0.004
T43.6 Psychostimulants with abuse potential	0.000	0.996	0.004
I45 Other conduction disorders	0.000	0.996	0.004
T82.4 Mechanical complication of vascular dialysis catheter	0.000	0.996	0.004
T40.2 Other opioids	0.000	0.996	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
Z40.9 Prophylactic surgery, unspecified	0.000	0.996	0.004
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.004	0.996	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.004	0.996	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.996	0.004
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.996	0.004
T38.7 Androgens and anabolic congeners	0.000	0.996	0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.996	0.004
T38.5 Other oestrogens and progestogens	0.000	0.996	0.004
T38.4 Oral contraceptives	0.000	0.996	0.004
T38.2 Antithyroid drugs	0.000	0.996	0.004
T38.1 Thyroid hormones and substitutes	0.000	0.996	0.004
T38.0 Glucocorticoids and synthetic analogues	0.000	0.996	0.004
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.004	0.996	0.000
T23.7 Corrosion of third degree of wrist and hand	0.004	0.996	0.000
T23.6 Corrosion of second degree of wrist and hand	0.004	0.996	0.000
T23.5 Corrosion of first degree of wrist and hand	0.004	0.996	0.000
T23.4 Corrosion of unspecified degree of wrist and hand	0.004	0.996	0.000
T23.1 Burn of first degree of wrist and hand	0.004	0.996	0.000
Chapter IX Diseases of the circulatory system	0.000	0.996	0.004
H43.2 Crystalline deposits in vitreous body	0.000	0.996	0.004
N97.9 Female infertility, unspecified	0.004	0.996	0.000
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft	0.000	0.996	0.004
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.004	0.996	0.000
I27.8 Other specified pulmonary heart diseases	0.000	0.996	0.004
I27.1 Kyphoscoliotic heart disease	0.000	0.996	0.004
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.996	0.004
M51 Other intervertebral disk disorders	0.004	0.996	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.996	0.004
T40.8 Lysergide [LSD]	0.000	0.996	0.004
T40.7 Cannabis (derivatives)	0.000	0.996	0.004
T40.6 Other and unspecified narcotics	0.000	0.996	0.004
T40.5 Cocaine	0.000	0.996	0.004
T40.3 Methadone	0.000	0.996	0.004
T40.1 Heroin	0.000	0.996	0.004
T40.0 Opium	0.000	0.996	0.004
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.004	0.996	0.000
M51.2 Other specified intervertebral disk displacement	0.004	0.996	0.000
I45.2 Bifascicular block	0.000	0.996	0.004
N88.8 Other specified noninflammatory disorders of cervix uteri	0.000	0.996	0.004
T23.3 Burn of third degree of wrist and hand	0.004	0.996	0.000
T82.0 Mechanical complication of heart valve prosthesis	0.000	0.996	0.004
D47.1 Chronic myeloproliferative disease	0.004	0.996	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.004	0.996	0.000
D37.0 Lip, oral cavity and pharynx	0.004	0.996	0.000
I45.3 Trifascicular block	0.000	0.996	0.004
T50.8 Diagnostic agents	0.000	0.996	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.996	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.996	0.003
T50.5 Appetite depressants	0.000	0.996	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.996	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.996	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.996	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.996	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.996	0.003
I45.6 Preexcitation syndrome	0.000	0.996	0.004
K81.1 Chronic cholecystitis	0.004	0.996	0.000
J03.9 Acute tonsillitis, unspecified	0.004	0.996	0.000
I44.0 Atrioventricular block, first degree	0.000	0.996	0.004
I33 Acute and subacute endocarditis	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.996	0.003
T47.7 Emetics	0.000	0.996	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.996	0.003
T47.5 Digestants	0.000	0.996	0.003
T47.4 Other laxatives	0.000	0.996	0.003
T47.3 Saline and osmotic laxatives	0.000	0.996	0.003
T47.2 Stimulant laxatives	0.000	0.996	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.996	0.003
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis	0.000	0.996	0.003
M51.9 Intervertebral disk disorder, unspecified	0.004	0.996	0.000
T20.1 Burn of first degree of head and neck	0.003	0.996	0.000
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.003	0.996	0.000
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.003	0.996	0.000
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.003	0.996	0.000
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.003	0.996	0.000
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.003	0.996	0.000
Z02.8 Other examinations for administrative purposes	0.000	0.996	0.004
D47.3 Essential (haemorrhagic) thrombocythaemia	0.003	0.996	0.000
F10.0 Acute intoxication	0.003	0.997	0.000
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.003	0.997	0.000
D37.6 Liver, gallbladder and bile ducts	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
I42 Cardiomyopathy	0.000	0.997	0.003
T20.7 Corrosion of third degree of head and neck	0.003	0.997	0.000
T20.6 Corrosion of second degree of head and neck	0.003	0.997	0.000
T20.5 Corrosion of first degree of head and neck	0.003	0.997	0.000
T20.4 Corrosion of unspecified degree of head and neck	0.003	0.997	0.000
T20.3 Burn of third degree of head and neck	0.003	0.997	0.000
T20.0 Burn of unspecified degree of head and neck	0.003	0.997	0.000
I36 Nonrheumatic tricuspid valve disorders	0.000	0.997	0.003
T20.2 Burn of second degree of head and neck	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.000	0.997	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
T36.6 Rifamycins	0.000	0.997	0.003
T36.5 Aminoglycosides	0.000	0.997	0.003
T36.4 Tetracyclines	0.000	0.997	0.003
T36.3 Macrolides	0.000	0.997	0.003
T36.2 Chloramphenicol group	0.000	0.997	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.003
D37.7 Other digestive organs	0.003	0.997	0.000
D37.2 Small intestine	0.003	0.997	0.000
T82.3 Mechanical complication of other vascular grafts	0.000	0.997	0.003
D44.1 Adrenal gland	0.003	0.997	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
I45.8 Other specified conduction disorders	0.000	0.997	0.003
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.003	0.997	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.003	0.997	0.000
I33.0 Acute and subacute infective endocarditis	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
D46.9 Myelodysplastic syndrome, unspecified	0.003	0.997	0.000
D48.5 Skin	0.003	0.997	0.000
T25.7 Corrosion of third degree of ankle and foot	0.003	0.997	0.000
T25.6 Corrosion of second degree of ankle and foot	0.003	0.997	0.000
T25.5 Corrosion of first degree of ankle and foot	0.003	0.997	0.000
T25.4 Corrosion of unspecified degree of ankle and foot	0.003	0.997	0.000
T25.3 Burn of third degree of ankle and foot	0.003	0.997	0.000
T25.2 Burn of second degree of ankle and foot	0.003	0.997	0.000
T25.1 Burn of first degree of ankle and foot	0.003	0.997	0.000
T25.0 Burn of unspecified degree of ankle and foot	0.003	0.997	0.000
I28 Other diseases of pulmonary vessels	0.000	0.997	0.003
D47.4 Osteomyelofibrosis	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
D48.1 Connective and other soft tissue	0.003	0.997	0.000
D48.0 Bone and articular cartilage	0.003	0.997	0.000
M51.8 Other specified intervertebral disk disorders	0.003	0.997	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.003	0.997	0.000
I52 Other heart disorders in diseases classified elsewhere	0.000	0.997	0.003
I48 Atrial fibrillation and flutter	0.000	0.997	0.003
I43 Cardiomyopathy in diseases classified elsewhere	0.000	0.997	0.003
I41 Myocarditis in diseases classified elsewhere	0.000	0.997	0.003
I40 Acute myocarditis	0.000	0.997	0.003
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.000	0.997	0.003
I32 Pericarditis in diseases classified elsewhere	0.000	0.997	0.003
D44.4 Craniopharyngeal duct	0.003	0.997	0.000
D46.7 Other myelodysplastic syndromes	0.003	0.997	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.003	0.997	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.003	0.997	0.000
D46.4 Refractory anaemia, unspecified	0.003	0.997	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.003	0.997	0.000
D46.1 Refractory anaemia with sideroblasts	0.003	0.997	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations